The Role of Sentinel Node (SLN) Procedure After Neo-adjuvant Chemotherapy (NACT) for Node Positive Breast Cancer (NPBC)

被引：0
|
作者：
Dockx, Y. [1 ]
Huizing, M. T. [1 ]
Huyghe, I. [1 ]
Altintas, S. [1 ]
Van den Wyngaert, T. [1 ]
Van Goethem, M. [1 ]
Vervliet, J. [2 ]
Van Marck, V. [1 ]
Sonnemans, H. [1 ]
Tjalma, W. A. [1 ]
机构：
[1] Univ Antwerp Hosp, Edegem, Belgium
[2] Az St Dimpna, Gynaecol, Geel, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [31] 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) as early imaging biomarker of axillary sentinel lymph node (SLN) status in locally advanced node-positive breast cancer (NPBC) patients (pts) receiving neoadjuvant chemotherapy (NACT)
    Dockx, Yanina
    Huizing, Manon Thirza
    Van den Wyngaert, Tim
    Altintas, Sevilay
    Huyghe, Ivan
    Geboers, Inge
    Vervliet, Johan
    Molderez, Christoph
    van Goethem, Mireille
    van Marck, Veerle
    Sonnemans, Hetty
    Tjalma, Wiebren
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Axillary Lymphadenectomy Assessment in Breast Cancer and Positive Sentinel Lymph Node (SLN)
    Rebollo, A. C.
    Sanchez, R.
    Aroui, T.
    Navarro-Pelayo, M.
    Guzman, G. I.
    Pastor, E.
    Garcia, J.
    Menjon, S.
    LLamas, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S564 - S564
  • [33] Is Sentinel Lymph Node Biopsy a Viable Alternative to Axillary Lymph Node Dissection in Breast Carcinoma Patients Who Have Received Neo-Adjuvant Chemotherapy?
    Sulthana, Rehena
    Singh, Akshita
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [34] Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy
    Beek, M. A.
    Tetteroo, E.
    Luiten, E. J. T.
    Gobardhan, P. D.
    Rutten, H. J. T.
    Heijns, J. B.
    Voogd, A. C.
    Klompenhouwer, E. G.
    EJSO, 2016, 42 (05): : 672 - 678
  • [35] Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy
    Beek, M.
    Tetteroo, E.
    Luiten, E.
    Gobardhan, P.
    Rutten, H.
    Heijns, J.
    Voogd, A.
    Klompenhouwer, E.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S58 - S59
  • [36] Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer
    Yagata, Hiroshi
    Yamauchi, Hideko
    Tsugawa, Koichiro
    Hayashi, Naoki
    Yoshida, Atsushi
    Kajiura, Yuka
    In, Reika
    Matsuda, Naoko
    Nakamura, Seigo
    CLINICAL BREAST CANCER, 2013, 13 (06) : 471 - 477
  • [37] Second Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Positive Sentinel Lymph Node (SLN) of Breast Cancer Prior to Treatment. Prelimenary Studies.
    Rebollo, A. C.
    Sanchez, R.
    Aroui, T.
    Navarro-Pelayo, M.
    Guzman, G. I.
    Pastor, E.
    Garcia, J.
    Menjon, S.
    Llamas, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S564 - S564
  • [38] The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer
    Alvarado, Rosalinda
    Yi, Min
    Le-Petross, Huong
    Gilcrease, Michael
    Mittendorf, Elizabeth A.
    Bedrosian, Isabelle
    Hwang, Rosa F.
    Caudle, Abigail S.
    Babiera, Gildy V.
    Akins, Jeri S.
    Kuerer, Henry M.
    Hunt, Kelly K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (10) : 3177 - 3184
  • [39] Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
    Sternberg, CN
    ANNALS OF ONCOLOGY, 2002, 13 : 273 - 279
  • [40] The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer
    Rosalinda Alvarado
    Min Yi
    Huong Le-Petross
    Michael Gilcrease
    Elizabeth A. Mittendorf
    Isabelle Bedrosian
    Rosa F. Hwang
    Abigail S. Caudle
    Gildy V. Babiera
    Jeri S. Akins
    Henry M. Kuerer
    Kelly K. Hunt
    Annals of Surgical Oncology, 2012, 19 : 3177 - 3184
12345